In high-grade prostate cancer, tumour-infiltrating lymphocytes (TILs) expressed high levels of the androgen receptor and prostate-specific membrane antigen but less PSA antigen when compared to low-grade prostate cancer [39]. This evidence concerns the gene FOLH1 and prostate carcinoma.